Insider Transactions Reported by 18 Insiders of Galera Therapeutics, Inc.

Symbol
GRTX on OTC
Location
Malvern, PA

Insiders trading volume in the past year

Galera Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yair Schneid 10%+ Owner $2,099,780 17 Apr 2024
Rochel Soffer 10%+ Owner $1,150,059 16 Apr 2024
Dr. Nancy T. Chang Director, 10%+ Owner $499,979 24 Feb 2025
Altamont Pharmaceutical Holdings, LLC 10%+ Owner $157,572 31 Dec 2023
Mark Bachleda Chief Commercial Officer $11,770 16 Mar 2023
Chris Degnan Chief Financial Officer $10,700 13 Mar 2023
J. Mel Sorensen President and CEO, Director $3,920 -$1,407 -26% 20 Nov 2025
Linda West Director 01 Jul 2023
Emmett Cunningham Director 14 Jun 2023
Joel F. Sussman Chief Accounting Officer 01 May 2025
HOLMLUND JON T Chief Medical Officer 28 Feb 2022
Lawrence M. Alleva Director 24 Feb 2025
Eugene P. Kennedy Chief Medical Officer 25 Feb 2023
MICHAEL R. FRIEDMAN Director 24 Feb 2025
MICHAEL POWELL Director 14 Jun 2023
Robert A. Beardsley Chief Operating Officer 25 Feb 2023
Jennifer Evans Stacey Chief Legal & Compliance Officer 25 Feb 2023
KEVIN G. LOKAY Director 24 Feb 2025

Recent Insider Transactions by Companies or Individuals for Galera Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
J. Mel Sorensen GRTX Common Stock Sale -26.4% $1,407 $0.0201 -70,000 195,029 20 Nov 2025 Direct
Joel F. Sussman GRTX Stock Option (Right to Buy) Award 2,000,000 2,000,000 01 May 2025 Direct
J. Mel Sorensen GRTX Stock Option (Right to Buy) Award 6,000,000 6,000,000 01 May 2025 Direct
KEVIN G. LOKAY GRTX Stock Option (Right to Buy) Award 48,000 48,000 24 Feb 2025 Direct
MICHAEL R. FRIEDMAN GRTX Stock Option (Right to Buy) Award 96,000 96,000 24 Feb 2025 Direct
CHANG NANCY T. GRTX Stock Option (Right to Buy) Award 96,000 96,000 24 Feb 2025 Direct
Lawrence M. Alleva GRTX Stock Option (Right to Buy) Award 48,000 48,000 24 Feb 2025 Direct
CHANG NANCY T. GRTX Common Stock Purchase $499,979 $0.0654 7,644,932 7,644,932 30 Dec 2024 Direct
CHANG NANCY T. GRTX Series B Preferred Stock Award 1,842 1,842 30 Dec 2024 Direct
MICHAEL R. FRIEDMAN GRTX Series B Preferred Stock Award 8,326 8,326 30 Dec 2024 See Footnote
Mel Sorensen GRTX Common Stock Sale -20.2% $4,825 $0.0720 -67,015 265,029 16 Aug 2024 Direct
Yair Schneid GRTX Common Stock Purchase 0.93% $19,396 $0.1940 100,000 10,823,610 19 Apr 2024 Direct
Yair Schneid GRTX Common Stock Purchase 5.38% $107,395 $0.1961 547,600 10,723,610 18 Apr 2024 Direct
Yair Schneid GRTX Common Stock Purchase 21.7% $403,185 $0.2222 1,814,657 10,176,010 17 Apr 2024 Direct
Altamont Pharmaceutical Holdings, LLC GRTX Common Stock Sale -39.1% $101,120 $0.1459 -693,076 1,080,000 28 Mar 2024 See fn.
Altamont Pharmaceutical Holdings, LLC GRTX Common Stock Sale -14.8% $52,146 $0.1699 -306,924 1,773,076 27 Mar 2024 See fn.
Altamont Pharmaceutical Holdings, LLC GRTX Common Stock Sale -49% $393,000 $0.1965 -2,000,000 2,080,000 26 Mar 2024 See fn.
Altamont Pharmaceutical Holdings, LLC GRTX Common Stock Sale -16% $170,742 $0.2189 -780,000 4,080,000 25 Mar 2024 See fn.
Altamont Pharmaceutical Holdings, LLC GRTX Common Stock Sale -0.41% $4,600 $0.2300 -20,000 4,860,000 22 Mar 2024 See fn.
Yair Schneid GRTX Common Stock Purchase 1.9% $25,650 $0.1710 150,000 8,043,203 08 Feb 2024 Direct
Yair Schneid GRTX Common Stock Purchase 2.27% $30,185 $0.1725 175,000 7,893,203 07 Feb 2024 Direct
Yair Schneid GRTX Common Stock Purchase 0.32% $5,025 $0.2010 25,000 7,718,203 06 Feb 2024 Direct
Yair Schneid GRTX Common Stock Purchase 1.28% $17,922 $0.1840 97,402 7,693,203 05 Feb 2024 Direct
Yair Schneid GRTX Common Stock Purchase 4.61% $60,635 $0.1810 335,000 7,595,801 30 Jan 2024 Direct
Yair Schneid GRTX Common Stock Purchase 2.11% $27,000 $0.1800 150,000 7,260,801 29 Jan 2024 Direct
Altamont Pharmaceutical Holdings, LLC GRTX Common Stock Sale -7.58% $90,240 $0.2256 -400,000 4,880,000 11 Jan 2024 See fn.
Linda West GRTX Stock Option (Right to Buy) Award 23,382 23,382 01 Jul 2023 Direct
Lawrence M. Alleva GRTX Stock Option (Right to Buy) Award 22,762 22,762 01 Jul 2023 Direct
Linda West GRTX Stock Option (Right to Buy) Award 48,000 48,000 14 Jun 2023 Direct
Emmett Cunningham GRTX Stock Option (Right to Buy) Award 48,000 0 14 Jun 2023 Direct
Lawrence M. Alleva GRTX Stock Option (Right to Buy) Award 48,000 48,000 14 Jun 2023 Direct
KEVIN G. LOKAY GRTX Stock Option (Right to Buy) Award 48,000 48,000 14 Jun 2023 Direct
MICHAEL POWELL GRTX Stock Option (Right to Buy) Award 64,000 64,000 14 Jun 2023 Direct
Mark Bachleda GRTX Common Stock Purchase 11,000 11,000 16 Mar 2023 Direct
Chris Degnan GRTX Common Stock Purchase 10,000 10,000 13 Mar 2023 Direct
Mel Sorensen GRTX Common Stock Purchase 43.1% 100,000 332,044 10 Mar 2023 Direct
Chris Degnan GRTX Stock Option (Right to Buy) Award 185,000 185,000 25 Feb 2023 Direct
Eugene P. Kennedy GRTX Stock Option (Right to Buy) Award 55,000 55,000 25 Feb 2023 Direct
Mark Bachleda GRTX Stock Option (Right to Buy) Award 135,000 135,000 25 Feb 2023 Direct
Mel Sorensen GRTX Stock Option (Right to Buy) Award 440,000 440,000 25 Feb 2023 Direct
Jennifer Evans Stacey GRTX Stock Option (Right to Buy) Award 135,000 135,000 25 Feb 2023 Direct
Robert A. Beardsley GRTX Stock Option (Right to Buy) Award 135,000 135,000 25 Feb 2023 Direct
Robert A. Beardsley GRTX Common Stock Options Exercise 10.2% 10,000 108,191 21 Nov 2022 Direct
Robert A. Beardsley GRTX Stock Option Options Exercise -11.7% -10,000 75,651 21 Nov 2022 Direct
Robert A. Beardsley GRTX Common Stock Options Exercise 11.3% 10,000 98,191 12 Sep 2022 Direct
Robert A. Beardsley GRTX Stock Option Options Exercise -10.4% -10,000 85,651 12 Sep 2022 Direct
Eugene P. Kennedy GRTX Stock Option (Right to Buy) Award 150,000 150,000 01 Sep 2022 Direct
Lawrence M. Alleva GRTX Common Stock Gift -63.2% -4,000 2,325 18 Jul 2022 Direct
Linda West GRTX Stock Option (Right to Buy) Award 58,496 58,496 01 Jul 2022 Direct
Linda West GRTX Stock Option (Right to Buy) Award 15,000 15,000 15 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.